<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ClinVarVariationRelease xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/clinvar_variation/variation_archive_1.10.xsd" ReleaseDate="2021-01-02">
<VariationArchive VariationID="428898" VariationName="NM_001126112.2(TP53):c.993+1del" VariationType="Deletion" DateCreated="2017-06-29" DateLastUpdated="2021-01-02" Accession="VCV000428898" Version="5" RecordType="interpreted" NumberOfSubmissions="3" NumberOfSubmitters="3">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <InterpretedRecord>
    <SimpleAllele AlleleID="420638" VariationID="428898">
      <GeneList>
        <Gene Symbol="TP53" FullName="tumor protein p53" GeneID="7157" HGNC_ID="HGNC:11998" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7668421" stop="7687490" display_start="7668421" display_stop="7687490" Strand="-"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7571719" stop="7590867" display_start="7571719" display_stop="7590867" Strand="-"/>
          </Location>
          <OMIM>191170</OMIM>
          <Haploinsufficiency last_evaluated="2016-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP53">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TP53">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
        </Gene>
      </GeneList>
      <Name>NM_001126112.2(TP53):c.993+1del</Name>
      <CanonicalSPDI>NC_000017.11:7673533:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7673534" stop="7673534" display_start="7673534" display_stop="7673534" variantLength="1" positionVCF="7673533" referenceAlleleVCF="AC" alternateAlleleVCF="A"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7576852" stop="7576852" display_start="7576852" display_stop="7576852" variantLength="1" positionVCF="7576851" referenceAlleleVCF="AC" alternateAlleleVCF="A"/>
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_321t5" sequenceAccession="LRG_321t5">
            <Expression>LRG_321t5:c.597+1del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_321t6" sequenceAccession="LRG_321t6">
            <Expression>LRG_321t6:c.597+1del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_321t7" sequenceAccession="LRG_321t7">
            <Expression>LRG_321t7:c.597+1del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_321t8" sequenceAccession="LRG_321t8">
            <Expression>LRG_321t8:c.876+1del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_321t1" sequenceAccession="LRG_321t1">
            <Expression>LRG_321t1:c.993+1del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_321t2" sequenceAccession="LRG_321t2">
            <Expression>LRG_321t2:c.993+1del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7576853del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7576853del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.7673535del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.7673535del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126112.2" sequenceAccession="NM_001126112" sequenceVersion="2" change="c.993+1del">
            <Expression>NM_001126112.2:c.993+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000546.5" sequenceAccession="NM_000546" sequenceVersion="5" change="c.993+1del">
            <Expression>NM_000546.5:c.993+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126113.2" sequenceAccession="NM_001126113" sequenceVersion="2" change="c.993+1del">
            <Expression>NM_001126113.2:c.993+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126114.2" sequenceAccession="NM_001126114" sequenceVersion="2" change="c.993+1del">
            <Expression>NM_001126114.2:c.993+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126118.1" sequenceAccession="NM_001126118" sequenceVersion="1" change="c.876+1del">
            <Expression>NM_001126118.1:c.876+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276761.2" sequenceAccession="NM_001276761" sequenceVersion="2" change="c.876+1del">
            <Expression>NM_001276761.2:c.876+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276760.2" sequenceAccession="NM_001276760" sequenceVersion="2" change="c.876+1del">
            <Expression>NM_001276760.2:c.876+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276695.2" sequenceAccession="NM_001276695" sequenceVersion="2" change="c.876+1del">
            <Expression>NM_001276695.2:c.876+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276696.2" sequenceAccession="NM_001276696" sequenceVersion="2" change="c.876+1del">
            <Expression>NM_001276696.2:c.876+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126115.1" sequenceAccession="NM_001126115" sequenceVersion="1" change="c.597+1del">
            <Expression>NM_001126115.1:c.597+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126117.1" sequenceAccession="NM_001126117" sequenceVersion="1" change="c.597+1del">
            <Expression>NM_001126117.1:c.597+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126116.1" sequenceAccession="NM_001126116" sequenceVersion="1" change="c.597+1del">
            <Expression>NM_001126116.1:c.597+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276697.2" sequenceAccession="NM_001276697" sequenceVersion="2" change="c.516+1del">
            <Expression>NM_001276697.2:c.516+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276699.2" sequenceAccession="NM_001276699" sequenceVersion="2" change="c.516+1del">
            <Expression>NM_001276699.2:c.516+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276698.2" sequenceAccession="NM_001276698" sequenceVersion="2" change="c.516+1del">
            <Expression>NM_001276698.2:c.516+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_321t4" sequenceAccession="LRG_321t4">
            <Expression>LRG_321t4:c.993+1del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_321t3" sequenceAccession="LRG_321t3">
            <Expression>LRG_321t3:c.993+1del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000546.5" sequenceAccession="NM_000546" sequenceVersion="5" change="c.993+1delG">
            <Expression>NM_000546.5(TP53):c.993+1delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000546.5" sequenceAccession="NM_000546" sequenceVersion="5" change="c.993+1delG">
            <Expression>NM_000546.5:c.993+1delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_321" sequenceAccession="LRG_321">
            <Expression>LRG_321:g.19017del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017013.2" sequenceAccession="NG_017013" sequenceVersion="2" change="g.19017del">
            <Expression>NG_017013.2:g.19017del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645369685" DB="ClinGen"/>
        <XRef Type="rs" ID="1131691033" DB="dbSNP"/>
      </XRefList>
    </SimpleAllele>
    <ReviewStatus>reviewed by expert panel</ReviewStatus>
    <RCVList>
      <RCVAccession Title="NM_001126112.2(TP53):c.993+1del AND Hereditary cancer-predisposing syndrome" DateLastEvaluated="2014-04-25" ReviewStatus="criteria provided, single submitter" Interpretation="Pathogenic" SubmissionCount="1" Accession="RCV000492434" Version="1">
        <InterpretedConditionList TraitSetID="13598">
          <InterpretedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
      <RCVAccession Title="NM_001126112.2(TP53):c.993+1del AND Li-Fraumeni syndrome" DateLastEvaluated="2019-08-28" ReviewStatus="reviewed by expert panel" Interpretation="Pathogenic" SubmissionCount="2" Accession="RCV000991147" Version="2">
        <InterpretedConditionList TraitSetID="2589">
          <InterpretedCondition DB="MedGen" ID="C0085390">Li-Fraumeni syndrome</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
    </RCVList>
    <Interpretations>
      <Interpretation DateLastEvaluated="2019-08-28" NumberOfSubmissions="3" NumberOfSubmitters="3" Type="Clinical significance">
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10980596</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/a608c703-2232-4c79-86dd-00844776434d</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH"/>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance"/>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet"/>
              <XRef ID="C0027672" DB="MedGen"/>
              <XRef ID="MONDO:0015356" DB="MONDO"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="2589" Type="Disease">
            <Trait ID="10539" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Li-Fraumeni syndrome</ElementValue>
                <XRef ID="li-fraumeni-syndrome" DB="Genetics Home Reference"/>
                <XRef Type="Phenotypic series" ID="PS151623" DB="OMIM"/>
                <XRef ID="428850001" DB="SNOMED CT"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sarcoma family syndrome of Li and Fraumeni</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LFS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6902"/>
                <XRef ID="6902" DB="Office of Rare Diseases"/>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Li-Fraumeni syndrome (LFS) is a cancer predisposition syndrome associated with high risks for a diverse spectrum of childhood- and adult-onset malignancies. The lifetime risk of cancer in individuals with LFS is =70% for men and =90% for women. Five cancer types account for the majority of LFS tumors: adrenocortical carcinomas, breast cancer, central nervous system tumors, osteosarcomas, and soft-tissue sarcomas. LFS is associated with an increased risk of several additional cancers including leukemia, lymphoma, gastrointestinal cancers, cancers of head and neck, kidney, larynx, lung, skin (e.g., melanoma), ovary, pancreas, prostate, testis, and thyroid. Individuals with LFS are at increased risk for cancer in childhood and young adulthood; survivors are at increased risk for multiple primary cancers.</Attribute>
                <XRef ID="NBK1311" DB="GeneReviews"/>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301488</ID>
                <ID Source="BookShelf">NBK1311</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACS, 2007">
                <ID Source="PubMed">17392385</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <XRef ID="524" DB="Orphanet"/>
              <XRef ID="C0085390" DB="MedGen"/>
              <XRef ID="MONDO:0018875" DB="MONDO"/>
              <XRef Type="Phenotypic series" ID="PS151623" DB="OMIM"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </Interpretation>
    </Interpretations>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="2253716" DateCreated="2020-01-10" DateLastUpdated="2020-07-22" SubmissionDate="2019-09-23">
        <ClinVarSubmissionID localKey="a608c703-2232-4c79-86dd-00844776434d" localKeyIsSubmitted="1" submittedAssembly="GRCh38"/>
        <ClinVarAccession Accession="SCV001142556" Type="SCV" Version="1" SubmitterName="ClinGen TP53 Variant Curation Expert Panel,ClinGen" OrgID="507142" OrganizationCategory="consortium"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Interpretation DateLastEvaluated="2019-08-28">
          <Description>Pathogenic</Description>
          <Citation>
            <ID Source="PubMed">10980596</ID>
          </Citation>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/a608c703-2232-4c79-86dd-00844776434d</URL>
          </Citation>
          <Comment>The c.993+1delG variant is predicted to result in a premature stop codon that leads to a truncated or absent protein (PVS1). This variant is absent in the gnomAD cohort (PM2_Supporting; http://gnomad.broadinstitute.org). This variant has been reported in a proband meeting classic Li-Fraumeni syndrome criteria (PS4_Supporting; PMID: 10980596). This variant was found to co-segregation with disease in multiple affected family members, with 5 meioses observed (PP1_Moderate; PMID: 10980596). In summary, TP53 c.993+1delG meets criteria to be classified as pathogenic for Li-Fraumeni syndrome. ACMG/AMP criteria applied, as specified by the TP53 Variant Curation Expert Panel: PVS1, PM2_Supporting, PS4_Supporting, PP1_Moderate.</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen TP53 ACMG Specifications v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/n2mxzzq1/clingen_tp53_acmg_specifications_v1.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP53"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000546.5(TP53):c.993+1delG</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.7673534delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA524"/>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6336842</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2702937" DateCreated="2020-07-06" DateLastUpdated="2020-07-11" SubmissionDate="2020-07-01">
        <ClinVarSubmissionID localKey="NM_000546.5:c.993+1delG|MedGen:C0085390" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV001370554" Type="SCV" Version="1" SubmitterName="Integrated Genetics/Laboratory Corporation of America" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="IG"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2020-05-05">
          <Description>Pathogenic</Description>
          <Citation>
            <ID Source="PubMed">10980596</ID>
          </Citation>
          <Comment>Variant summary: TP53 c.993+1delG is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: four predict the variant abolishes a 5' splicing donor site. These predictions were confirmed by a publication that demonstrated exon 9 skipping in a patient derived immortalized cell line, and the lack of the variant-transcript in mRNA isolated from patient derived leukocytes (Verselis_2000). The variant was absent in 251342 control chromosomes (gnomAD). c.993+1delG has been reported in the literature in a large family, in multiple family members affected with various tumors belonging to the Li-Fraumeni Syndrome tumor spectrum (Verselis_2000); this family met the classic Li-Fraumeni syndrome criteria, and the variant co-segregated with the disease in multiple family members. These data indicate that the variant is likely to be associated with disease. One submitter (i.e. ClinGen TP53 Variant Curation Expert Panel) has provided clinical-significance assessments for this variant in ClinVar after 2014, and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP53"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000546.5:c.993+1delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Li-Fraumeni syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0085390" Type="CUI"/>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7703337</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1132179" DateCreated="2017-06-29" DateLastUpdated="2020-12-08" SubmissionDate="2020-11-30">
        <ClinVarSubmissionID localKey="a97612" localKeyIsSubmitted="1" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000581155" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2014-04-25">
          <Description>Pathogenic</Description>
          <Comment>Ã¢â‚¬â€¹The c.993+1delG intronic pathogenic mutation results from a deletion of the first nucleotide after coding exon 8 of the TP53 gene. This mutation tracked with disease in a large family with multiple members diagnosed with a wide spectrum of Li-Fraumeni related cancers. RT-PCR analyses showed that this alteration, referred to as IVS9+1delG, led to exon 9 skipping (Verselis SJ et al. Oncogene. 2000 Aug 31;19(37):4230-5). In addition to the clinical data presented in the literature, since alterations that disrupt the canonical splice donor site are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294).</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Autosomal Dominant and X-Linked criteria (10/2015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/aH4uL7vL/mid-7377_ambry_classification_scheme_oct_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1"/>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TP53"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000546.4:c.993+1delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0027672" Type="CUI"/>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2702937" TraitType="Disease" MappingType="Name" MappingValue="Li-Fraumeni syndrome" MappingRef="Preferred">
        <MedGen CUI="C0085390" Name="Li-Fraumeni syndrome"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1132179" TraitType="Disease" MappingType="Name" MappingValue="Hereditary cancer-predisposing syndrome" MappingRef="Preferred">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2253716" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA524" MappingRef="Orphanet">
        <MedGen CUI="C0085390" Name="Li-Fraumeni syndrome"/>
      </TraitMapping>
    </TraitMappingList>
  </InterpretedRecord>
</VariationArchive>

<VariationArchive VariationID="429070" VariationName="NM_000051.3(ATM):c.2639-384A&gt;G" VariationType="single nucleotide variant" DateCreated="2017-06-30" DateLastUpdated="2021-01-02" Accession="VCV000429070" Version="5" RecordType="interpreted" NumberOfSubmissions="3" NumberOfSubmitters="3">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <InterpretedRecord>
    <SimpleAllele AlleleID="421073" VariationID="429070">
      <GeneList>
        <Gene Symbol="ATM" FullName="ATM serine/threonine kinase" GeneID="472" HGNC_ID="HGNC:795" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="108222484" stop="108369102" display_start="108222484" display_stop="108369102" Strand="+"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="108093558" stop="108239825" display_start="108093558" display_stop="108239825" Strand="+"/>
          </Location>
          <OMIM>607585</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATM">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATM">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000051.3(ATM):c.2639-384A&gt;G</Name>
      <CanonicalSPDI>NC_000011.10:108268025:A:G</CanonicalSPDI>
      <VariantType>single nucleotide variant</VariantType>
      <Location>
        <CytogeneticLocation>11q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="108268026" stop="108268026" display_start="108268026" display_stop="108268026" variantLength="1" positionVCF="108268026" referenceAlleleVCF="A" alternateAlleleVCF="G"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="108138753" stop="108138753" display_start="108138753" display_stop="108138753" variantLength="1" positionVCF="108138753" referenceAlleleVCF="A" alternateAlleleVCF="G"/>
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.108268026A&gt;G" Assembly="GRCh38">
            <Expression>NC_000011.10:g.108268026A&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.108138753A&gt;G" Assembly="GRCh37">
            <Expression>NC_000011.9:g.108138753A&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351834.2" sequenceAccession="NM_001351834" sequenceVersion="2" change="c.2639-384A&gt;G">
            <Expression>NM_001351834.2:c.2639-384A&gt;G</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000051.3" sequenceAccession="NM_000051" sequenceVersion="3" change="c.2639-384A&gt;G">
            <Expression>NM_000051.3:c.2639-384A&gt;G</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_135t1" sequenceAccession="LRG_135t1" change="c.2639-384A&gt;G">
            <Expression>LRG_135t1:c.2639-384A&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009830.1" sequenceAccession="NG_009830" sequenceVersion="1" change="g.50195A&gt;G">
            <Expression>NG_009830.1:g.50195A&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_135" sequenceAccession="LRG_135" change="g.50195A&gt;G">
            <Expression>LRG_135:g.50195A&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA601698081" DB="ClinGen"/>
        <XRef Type="rs" ID="1131691154" DB="dbSNP"/>
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)"/>
        <AlleleFrequency Value="0.00003" Source="The Genome Aggregation Database (gnomAD)"/>
      </AlleleFrequencyList>
    </SimpleAllele>
    <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
    <RCVList>
      <RCVAccession Title="NM_000051.3(ATM):c.2639-384A&gt;G AND Hereditary cancer-predisposing syndrome" DateLastEvaluated="2020-07-14" ReviewStatus="criteria provided, multiple submitters, no conflicts" Interpretation="Likely pathogenic" SubmissionCount="2" Accession="RCV000493875" Version="3">
        <InterpretedConditionList TraitSetID="13598">
          <InterpretedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
      <RCVAccession Title="NM_000051.3(ATM):c.2639-384A&gt;G AND Ataxia-telangiectasia syndrome" DateLastEvaluated="2020-09-16" ReviewStatus="no assertion criteria provided" Interpretation="Likely pathogenic" SubmissionCount="1" Accession="RCV001271168" Version="1">
        <InterpretedConditionList TraitSetID="770">
          <InterpretedCondition DB="MedGen" ID="C0004135">Ataxia-telangiectasia syndrome</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
    </RCVList>
    <Interpretations>
      <Interpretation DateLastEvaluated="2020-07-14" NumberOfSubmissions="3" NumberOfSubmitters="3" Type="Clinical significance">
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22006793</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24506781</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31050087</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH"/>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance"/>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet"/>
              <XRef ID="C0027672" DB="MedGen"/>
              <XRef ID="MONDO:0015356" DB="MONDO"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="770" Type="Disease">
            <Trait ID="4635" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Louis-Bar syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebello-oculocutaneous telangiectasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency with ataxia telangiectasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ataxia-telangiectasia syndrome</ElementValue>
                <XRef ID="Ataxia+Telangiectasia/637" DB="Genetic Alliance"/>
                <XRef ID="68504005" DB="SNOMED CT"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-telangiectasia, complementation group D</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AT, COMPLEMENTATION GROUP C</ElementValue>
                <XRef ID="208900" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATAXIA-TELANGIECTASIA, COMPLEMENTATION GROUP A</ElementValue>
                <XRef Type="Allelic variant" ID="607585.0001" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATAXIA-TELANGIECTASIA, FRESNO VARIANT</ElementValue>
                <XRef Type="Allelic variant" ID="607585.0014" DB="OMIM"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-telangiectasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-telangiectasia, complementation group E</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AT1</ElementValue>
                <XRef Type="MIM" ID="208900" DB="OMIM"/>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AT</ElementValue>
                <XRef Type="MIM" ID="208900" DB="OMIM"/>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">A-T</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATM</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATC</ElementValue>
                <XRef ID="208900" DB="OMIM"/>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATA</ElementValue>
                <XRef ID="208900" DB="OMIM"/>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATD</ElementValue>
                <XRef ID="208900" DB="OMIM"/>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATE</ElementValue>
                <XRef ID="208900" DB="OMIM"/>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5862"/>
                <XRef ID="5862" DB="Office of Rare Diseases"/>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301790</ID>
                <ID Source="BookShelf">NBK26468</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="EFNS/ENS, 2014">
                <ID Source="PubMed">24418350</ID>
              </Citation>
              <XRef ID="100" DB="Orphanet"/>
              <XRef ID="C0004135" DB="MedGen"/>
              <XRef ID="MONDO:0008840" DB="MONDO"/>
              <XRef Type="MIM" ID="208900" DB="OMIM"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </Interpretation>
    </Interpretations>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2652022" DateCreated="2020-06-19" DateLastUpdated="2020-06-22" SubmissionDate="2020-05-19">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkZ0ceL479kSI9-BOJSwAJaI|MedGen:C0027672" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV001343706" Type="SCV" Version="1" SubmitterName="Color" OrgID="505849" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2020-01-09">
          <Description>Likely pathogenic</Description>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000051.3:c.2639-384A&gt;G</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0027672" Type="CUI"/>
          </Trait>
        </TraitSet>
        <Comment>This variant causes an A&gt;G nucleotide substitution at the -384 position of intron 17 of the ATM gene. Functional RNA studies have shown that this variant causes retention of 58 base pairs from intron 17, creating a frameshift and premature translation stop signal (PMID: 22006793, 31050087). This variant has been reported in individuals affected with ataxia-telangiectasia (PMID: 22006793, 31050087). This variant has also been identified in 1/31396 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of ATM function is a known mechanism of disease. Based on the available evidence, this variant is classified as Likely Pathogenic.</Comment>
        <SubmissionNameList>
          <SubmissionName>Color Genomics - ClinVar Submission - May2020 - SUB747</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1133201" DateCreated="2017-06-30" DateLastUpdated="2020-12-08" SubmissionDate="2020-11-30">
        <ClinVarSubmissionID localKey="a96141" localKeyIsSubmitted="1" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000581450" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2020-07-14">
          <Description>Likely pathogenic</Description>
          <Citation>
            <ID Source="PubMed">22006793</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24506781</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31050087</ID>
          </Citation>
          <Comment>The c.2639-384A&gt;G intronic variant results from an A to G substitution 384 nucleotides upstream from coding exon 17 in the ATM gene. This alteration has been detected in conjunction with pathogenic ATM variants in individuals affected with ataxia-telangiectasia (Nakamura K et al. Hum. Mutat. 2012 Jan; 33(1):198-208, Fi&amp;eacute;vet A et al. Hum. Mutat., 2019 10;40:1713-1730). RNA studies have shown that this alteration creates a cryptic splice donor site and leads to the insertion of a 58-bp pseudoexon into the transcript, which is anticipated to result in nonsense mediated RNA decay (Nakamura K et al. Hum. Mutat. 2012 Jan; 33(1):198-208, Fi&amp;eacute;vet A et al. Hum. Mutat., 2019 10;40:1713-1730, Ambry internal data). Based on the majority of available evidence to date, this variant is likely to be pathogenic.</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Autosomal Dominant and X-Linked criteria (2/2020)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/izn1iuef/variant_classificationscheme_02.2020_ambry.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1"/>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000051.3:c.2639-384A&gt;G</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0027672" Type="CUI"/>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2867319" DateCreated="2020-12-30" DateLastUpdated="2021-01-01" SubmissionDate="2020-12-28">
        <ClinVarSubmissionID localKey="NM_000051.3:c.2639-384A&gt;G|Ataxia-telangiectasia" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV001452044" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Interpretation DateLastEvaluated="2020-09-16">
          <Description>Likely pathogenic</Description>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000051.3:c.2639-384A&gt;G</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Ataxia-telangiectasia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2867319" TraitType="Disease" MappingType="Name" MappingValue="Ataxia-telangiectasia" MappingRef="Preferred">
        <MedGen CUI="C0004135" Name="Ataxia-telangiectasia syndrome"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2652022" TraitType="Disease" MappingType="Name" MappingValue="Hereditary cancer-predisposing syndrome" MappingRef="Preferred">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1133201" TraitType="Disease" MappingType="Name" MappingValue="Hereditary cancer-predisposing syndrome" MappingRef="Preferred">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/>
      </TraitMapping>
    </TraitMappingList>
  </InterpretedRecord>
</VariationArchive>

<VariationArchive VariationID="429171" VariationName="NM_000143.3(FH):c.702T&gt;G (p.Thr234=)" VariationType="single nucleotide variant" DateCreated="2017-06-30" DateLastUpdated="2021-01-02" Accession="VCV000429171" Version="7" RecordType="interpreted" NumberOfSubmissions="4" NumberOfSubmitters="4">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <InterpretedRecord>
    <SimpleAllele AlleleID="421010" VariationID="429171">
      <GeneList>
        <Gene Symbol="FH" FullName="fumarate hydratase" GeneID="2271" HGNC_ID="HGNC:3700" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q43</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="241497603" stop="241519755" display_start="241497603" display_stop="241519755" Strand="-"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="241660856" stop="241683084" display_start="241660856" display_stop="241683084" Strand="-"/>
          </Location>
          <OMIM>136850</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FH">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FH">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000143.3(FH):c.702T&gt;G (p.Thr234=)</Name>
      <CanonicalSPDI>NC_000001.11:241508638:A:C</CanonicalSPDI>
      <VariantType>single nucleotide variant</VariantType>
      <Location>
        <CytogeneticLocation>1q43</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="241508639" stop="241508639" display_start="241508639" display_stop="241508639" variantLength="1" positionVCF="241508639" referenceAlleleVCF="A" alternateAlleleVCF="C"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="241671939" stop="241671939" display_start="241671939" display_stop="241671939" variantLength="1" positionVCF="241671939" referenceAlleleVCF="A" alternateAlleleVCF="C"/>
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_504" sequenceAccession="LRG_504" change="g.16116T&gt;G">
            <Expression>LRG_504:g.16116T&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.241671939A&gt;C" Assembly="GRCh37">
            <Expression>NC_000001.10:g.241671939A&gt;C</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.241508639A&gt;C" Assembly="GRCh38">
            <Expression>NC_000001.11:g.241508639A&gt;C</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000143.3" sequenceAccession="NM_000143" sequenceVersion="3" change="c.702T&gt;G">
            <Expression>NM_000143.3:c.702T&gt;G</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000134.2" sequenceAccession="NP_000134" sequenceVersion="2" change="p.Thr234=">
            <Expression>NP_000134.2:p.Thr234=</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001819" Type="synonymous variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_504t1" sequenceAccession="LRG_504t1" change="c.702T&gt;G">
            <Expression>LRG_504t1:c.702T&gt;G</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_504p1" sequenceAccession="LRG_504p1" change="p.Thr234=">
            <Expression>LRG_504p1:p.Thr234=</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012338.1" sequenceAccession="NG_012338" sequenceVersion="1" change="g.16116T&gt;G">
            <Expression>NG_012338.1:g.16116T&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA1478629" DB="ClinGen"/>
        <XRef Type="rs" ID="201083387" DB="dbSNP"/>
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00140" Source="1000 Genomes Project"/>
        <AlleleFrequency Value="0.00004" Source="Trans-Omics for Precision Medicine (TOPMed)"/>
        <AlleleFrequency Value="0.00048" Source="The Genome Aggregation Database (gnomAD), exomes"/>
        <AlleleFrequency Value="0.00054" Source="Exome Aggregation Consortium (ExAC)"/>
      </AlleleFrequencyList>
      <GlobalMinorAlleleFrequency Value="0.00140" Source="1000 Genomes Project" MinorAllele="C"/>
    </SimpleAllele>
    <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
    <RCVList>
      <RCVAccession Title="NM_000143.3(FH):c.702T&gt;G (p.Thr234=) AND Hereditary cancer-predisposing syndrome" DateLastEvaluated="2019-04-29" ReviewStatus="criteria provided, single submitter" Interpretation="Likely benign" SubmissionCount="1" Accession="RCV000494047" Version="2">
        <InterpretedConditionList TraitSetID="13598">
          <InterpretedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
      <RCVAccession Title="NM_000143.3(FH):c.702T&gt;G (p.Thr234=) AND not provided" DateLastEvaluated="2018-05-17" ReviewStatus="criteria provided, single submitter" Interpretation="Likely benign" SubmissionCount="1" Accession="RCV000827769" Version="3">
        <InterpretedConditionList TraitSetID="9460">
          <InterpretedCondition DB="MedGen" ID="CN517202">not provided</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
      <RCVAccession Title="NM_000143.3(FH):c.702T&gt;G (p.Thr234=) AND Fumarase deficiency" DateLastEvaluated="2019-12-31" ReviewStatus="criteria provided, single submitter" Interpretation="Benign" SubmissionCount="2" Accession="RCV001083333" Version="2">
        <InterpretedConditionList TraitSetID="5266">
          <InterpretedCondition DB="MedGen" ID="C0342770">Fumarase deficiency</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
    </RCVList>
    <Interpretations>
      <Interpretation DateLastEvaluated="2019-12-31" NumberOfSubmissions="4" NumberOfSubmitters="4" Type="Clinical significance">
        <Description>Benign/Likely benign</Description>
        <Citation Type="general">
          <ID Source="PubMed">19339519</ID>
        </Citation>
        <DescriptionHistory Dated="2020-03-24">
          <Description>Conflicting interpretations of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-12-26">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit,King Faisal Specialist Hospital &amp; Research Centre"/>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH"/>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance"/>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet"/>
              <XRef ID="C0027672" DB="MedGen"/>
              <XRef ID="MONDO:0015356" DB="MONDO"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="5266" Type="Disease">
            <Trait ID="2154" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Fumaric aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fumarase deficiency</ElementValue>
                <XRef ID="Fumaric+Aciduria/2963" DB="Genetic Alliance"/>
                <XRef ID="237983002" DB="SNOMED CT"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fumarate Hydratase Deficiency</ElementValue>
                <XRef ID="NBK1506" DB="GeneReviews"/>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FMRD</ElementValue>
                <XRef Type="MIM" ID="606812" DB="OMIM"/>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fumarate hydratase (FH) deficiency results in severe neonatal and early infantile encephalopathy that is characterized by poor feeding, failure to thrive, hypotonia, lethargy, and seizures. Dysmorphic facial features include frontal bossing, depressed nasal bridge, and widely spaced eyes. Many affected individuals are microcephalic. A spectrum of brain abnormalities are seen on magnetic resonance imaging, including cerebral atrophy, enlarged ventricles and generous extra-axial cerebral spinal fluid (CSF) spaces, delayed myelination for age, thinning of the corpus callosum, and an abnormally small brain stem. Brain malformations including bilateral polymicrogyria and absence of the corpus callosum can also be observed. Development is severely affected: most affected individuals are nonverbal and nonambulatory, and many die during early childhood. Less severely affected individuals with moderate cognitive impairment and long-term survival have been reported.</Attribute>
                <XRef ID="NBK1506" DB="GeneReviews"/>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301679</ID>
                <ID Source="BookShelf">NBK1506</ID>
              </Citation>
              <XRef ID="24" DB="Orphanet"/>
              <XRef ID="C0342770" DB="MedGen"/>
              <XRef ID="MONDO:0011730" DB="MONDO"/>
              <XRef Type="MIM" ID="606812" DB="OMIM"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </Interpretation>
    </Interpretations>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1897304" DateCreated="2019-08-24" DateLastUpdated="2020-10-08" SubmissionDate="2019-04-12">
        <ClinVarSubmissionID localKey="GDX:22121|Not Provided" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000969429" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2018-05-17">
          <Description>Likely benign</Description>
          <Comment>This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FH"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="C" referenceAllele="A" start="241671939" stop="241671939" variantLength="1"/>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000143.3:c.702T&gt;G</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5452872</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1224706" DateCreated="2017-12-20" DateLastUpdated="2020-05-05" SubmissionDate="2020-01-29">
        <ClinVarSubmissionID localKey="166369|MedGen:C0342770" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000632488" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2019-12-31">
          <Description>Benign</Description>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FH"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000143.3:c.702T&gt;G</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Fumarase deficiency</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0342770" Type="CUI"/>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6897608</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1133396" DateCreated="2017-06-30" DateLastUpdated="2020-12-08" SubmissionDate="2020-11-30">
        <ClinVarSubmissionID localKey="a49000" localKeyIsSubmitted="1" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000581640" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2019-04-29">
          <Description>Likely benign</Description>
          <Citation>
            <ID Source="PubMed">19339519</ID>
          </Citation>
          <Comment>Co-occurence with mutation in same gene (phase unknown);Other data supporting benign classification</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Autosomal Dominant and X-Linked criteria (3/2017)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/uwtx4ijy/ad_xl_classificationscheme_03.2017_ambry.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1"/>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FH"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000143.3:c.702T&gt;G</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0027672" Type="CUI"/>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2871170" DateCreated="2020-12-30" DateLastUpdated="2021-01-01" SubmissionDate="2020-12-28">
        <ClinVarSubmissionID localKey="NM_000143.3:c.702T&gt;G|Fumarase deficiency" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV001455895" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Interpretation DateLastEvaluated="2020-01-10">
          <Description>Benign</Description>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000143.3:c.702T&gt;G</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Fumarase deficiency</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1224706" TraitType="Disease" MappingType="Name" MappingValue="Fumarase deficiency" MappingRef="Preferred">
        <MedGen CUI="C0342770" Name="Fumarase deficiency"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1897304" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2871170" TraitType="Disease" MappingType="Name" MappingValue="Fumarase deficiency" MappingRef="Preferred">
        <MedGen CUI="C0342770" Name="Fumarase deficiency"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1133396" TraitType="Disease" MappingType="Name" MappingValue="Hereditary cancer-predisposing syndrome" MappingRef="Preferred">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/>
      </TraitMapping>
    </TraitMappingList>
  </InterpretedRecord>
</VariationArchive>

<VariationArchive VariationID="429303" VariationName="NM_000080.4(CHRNE):c.183_187dup (p.Leu63fs)" VariationType="Duplication" DateCreated="2017-06-30" DateLastUpdated="2021-01-02" Accession="VCV000429303" Version="4" RecordType="interpreted" NumberOfSubmissions="3" NumberOfSubmitters="3">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <InterpretedRecord>
    <SimpleAllele AlleleID="422179" VariationID="429303">
      <GeneList>
        <Gene Symbol="CHRNE" FullName="cholinergic receptor nicotinic epsilon subunit" GeneID="1145" HGNC_ID="HGNC:1966" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="4897771" stop="4905019" display_start="4897771" display_stop="4905019" Strand="-"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="4801063" stop="4806368" display_start="4801063" display_stop="4806368" Strand="-"/>
          </Location>
          <OMIM>100725</OMIM>
        </Gene>
        <Gene Symbol="C17orf107" FullName="chromosome 17 open reading frame 107" GeneID="100130311" HGNC_ID="HGNC:37238" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="4899536" stop="4902934" display_start="4899536" display_stop="4902934" Strand="+"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="4802947" stop="4806226" display_start="4802947" display_stop="4806226" Strand="+"/>
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000080.4(CHRNE):c.183_187dup (p.Leu63fs)</Name>
      <CanonicalSPDI>NC_000017.11:4902622:GTGAG:GTGAGGTGAG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="4902622" stop="4902623" display_start="4902622" display_stop="4902623" variantLength="5" positionVCF="4902622" referenceAlleleVCF="A" alternateAlleleVCF="AGTGAG"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="4805917" stop="4805918" display_start="4805917" display_stop="4805918" variantLength="5" positionVCF="4805917" referenceAlleleVCF="A" alternateAlleleVCF="AGTGAG"/>
      </Location>
      <ProteinChange>L63fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.4805918_4805922dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.4805918_4805922dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.4902623_4902627dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.4902623_4902627dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000080.4" sequenceAccession="NM_000080" sequenceVersion="4" change="c.183_187dup" MANESelect="true">
            <Expression>NM_000080.4:c.183_187dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000071.1" sequenceAccession="NP_000071" sequenceVersion="1" change="p.Leu63fs">
            <Expression>NP_000071.1:p.Leu63fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145536.2" sequenceAccession="NM_001145536" sequenceVersion="2" change="c.*2090_*2094dup" MANESelect="true">
            <Expression>NM_001145536.2:c.*2090_*2094dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000080.4" sequenceAccession="NM_000080" sequenceVersion="4" change="c.183_187dupCTCAC" MANESelect="true">
            <Expression>NM_000080.4:c.183_187dupCTCAC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000080.3" sequenceAccession="NM_000080" sequenceVersion="3" change="c.183_187dupCTCAC">
            <Expression>NM_000080.3:c.183_187dupCTCAC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1254t1" sequenceAccession="LRG_1254t1" change="c.183_187dup">
            <Expression>LRG_1254t1:c.183_187dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1254p1" sequenceAccession="LRG_1254p1" change="p.Leu63fs">
            <Expression>LRG_1254p1:p.Leu63fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008029.2" sequenceAccession="NG_008029" sequenceVersion="2" change="g.5449_5453dup">
            <Expression>NG_008029.2:g.5449_5453dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1254" sequenceAccession="LRG_1254" change="g.5449_5453dup">
            <Expression>LRG_1254:g.5449_5453dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA8314588" DB="ClinGen"/>
        <XRef Type="rs" ID="776927709" DB="dbSNP"/>
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)"/>
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes"/>
      </AlleleFrequencyList>
    </SimpleAllele>
    <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
    <RCVList>
      <RCVAccession Title="NM_000080.4(CHRNE):c.183_187dup (p.Leu63fs) AND not provided" DateLastEvaluated="2017-05-04" ReviewStatus="criteria provided, single submitter" Interpretation="Pathogenic" SubmissionCount="1" Accession="RCV000493520" Version="1">
        <InterpretedConditionList TraitSetID="9460">
          <InterpretedCondition DB="MedGen" ID="CN517202">not provided</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
      <RCVAccession Title="NM_000080.4(CHRNE):c.183_187dup (p.Leu63fs) AND Congenital myasthenic syndrome" DateLastEvaluated="2017-07-10" ReviewStatus="criteria provided, single submitter" Interpretation="Likely pathogenic" SubmissionCount="2" Accession="RCV000779224" Version="2">
        <InterpretedConditionList TraitSetID="9634">
          <InterpretedCondition DB="MedGen" ID="C0751882">Congenital myasthenic syndrome</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
    </RCVList>
    <Interpretations>
      <Interpretation DateLastEvaluated="2017-07-10" NumberOfSubmissions="3" NumberOfSubmitters="3" Type="Clinical significance">
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21150643</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27717316</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9158150</ID>
        </Citation>
        <DescriptionHistory Dated="2019-05-24">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9634" Type="Disease">
            <Trait ID="9474" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital myasthenic syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Congenital myasthenic syndromes (designated as CMS throughout this entry) are characterized by fatigable weakness of skeletal muscle (e.g., ocular, bulbar, limb muscles) with onset at or shortly after birth or in early childhood; rarely, symptoms may not manifest until later in childhood. Cardiac and smooth muscle are usually not involved. Severity and course of disease are highly variable, ranging from minor symptoms to progressive disabling weakness. In some subtypes of CMS, myasthenic symptoms may be mild, but sudden severe exacerbations of weakness or even sudden episodes of respiratory insufficiency may be precipitated by fever, infections, or excitement. Major findings of the neonatal-onset subtype include: respiratory insufficiency with sudden apnea and cyanosis; feeding difficulties; poor suck and cry; choking spells; eyelid ptosis; and facial, bulbar, and generalized weakness. Arthrogryposis multiplex congenita may also be present. Stridor in infancy may be an important clue to CMS. Later childhood-onset subtypes show abnormal muscle fatigability with difficulty in activities such as running or climbing stairs; motor milestones may be delayed; fluctuating eyelid ptosis and fixed or fluctuating extraocular muscle weakness are common presentations.</Attribute>
                <XRef ID="NBK1168" DB="GeneReviews"/>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301347</ID>
                <ID Source="BookShelf">NBK1168</ID>
              </Citation>
              <XRef ID="590" DB="Orphanet"/>
              <XRef ID="C0751882" DB="MedGen"/>
              <XRef ID="MONDO:0018940" DB="MONDO"/>
              <XRef Type="Phenotypic series" ID="PS601462" DB="OMIM"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit,King Faisal Specialist Hospital &amp; Research Centre"/>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </Interpretation>
    </Interpretations>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1133593" DateCreated="2017-06-30" DateLastUpdated="2019-05-09" SubmissionDate="2019-01-29">
        <ClinVarSubmissionID localKey="GDX:714831|Not Provided" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000581834" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2017-05-04">
          <Description>Pathogenic</Description>
          <Comment Type="public">The c.183_187dupCTCAC pathogenic variant in the CHRNE gene has been reported previously using alternative nomenclature (c.123_127dupCTCAC), in both compound heterozygous and homozygous states, in individuals with congenital myasthenia (Ohno et al., 1997; Salih et al., 2011). The c.183_187dupCTCAC variant causes a frameshift starting with codon Leucine 63, changes this amino acid to a Proline residue and creates a premature Stop codon at position 3 of the new reading frame, denoted p.Leu63ProfsX3. This variant is expected to cause loss of normal protein function either through nonsense-mediated mRNA decay or protein truncation. Functional studies indicate that CHRNE protein harboring the c.183_187dupCTCAC variant fails to assemble with the alpha subunit of the AChR (Ohno et al., 1997). The c.183_187dupCTCAC variant is not observed in large population cohorts (Lek et al., 2016; McVean et al., 2012; Exome Variant Server). We interpret c.183_187dupCTCAC as a pathogenic variant.</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHRNE"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="GTGAGGTGAG" referenceAllele="GTGAG" start="4805917" stop="4805918" variantLength="2"/>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000080.3:c.183_187dupCTCAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790844" DateCreated="2019-05-23" DateLastUpdated="2019-05-27" SubmissionDate="2019-02-01">
        <ClinVarSubmissionID localKey="1318346" localKeyIsSubmitted="1" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000915769" Type="SCV" Version="1" SubmitterName="Illumina Clinical Services Laboratory,Illumina" OrgID="504895" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2017-07-10">
          <Description>Likely pathogenic</Description>
          <Citation>
            <ID Source="PubMed">21150643</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9158150</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27717316</ID>
          </Citation>
          <Comment Type="public">The CHRNE c.183_187dupCTCAC (p.Leu63ProfsTer3) variant is a frameshift variant that is predicted to cause premature truncation of the protein. Across three studies of patients with congenital myasthenic syndrome, the p.Leu63ProfsTer3 variant has been identified in a homozygous state in four patients including three siblings from a consanguineous family, and in a compound heterozygous state in two affected siblings (Ohno et al. 1997; Salih et al. 2011; Chang et al. 2016). The p.Leu63ProfsTer3 variant was absent from 100 controls and is reported at a frequency of 0.00051 in the Ashkenazi Jewish population of the Genome Aggregation Database. Ohno et al. (1997) demonstrated in cultured cells that the p.Leu63ProfsTer3 variant leads to significantly reduced expression of the epsilon subunit of the acetylcholine receptor (CHRNE) compared to wild type. Based on the evidence, the p.Leu63ProfsTer3 variant is classified as likely pathogenic for the recessive form of congenital myasthenic syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHRNE"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="AGTGAG" referenceAllele="A" start="4805917" stop="4805917" variantLength="1"/>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000080.3:c.183_187dupCTCAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Congenital myasthenic syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0751882" Type="CUI"/>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2868414" DateCreated="2020-12-30" DateLastUpdated="2021-01-01" SubmissionDate="2020-12-28">
        <ClinVarSubmissionID localKey="NM_000080.4:c.183_187dupCTCAC|Congenital myasthenic syndrome" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV001453139" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Interpretation DateLastEvaluated="2020-09-16">
          <Description>Pathogenic</Description>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000080.4:c.183_187dupCTCAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Congenital myasthenic syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1790844" TraitType="Disease" MappingType="Name" MappingValue="Congenital myasthenic syndrome" MappingRef="Preferred">
        <MedGen CUI="C0751882" Name="Congenital myasthenic syndrome"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2868414" TraitType="Disease" MappingType="Name" MappingValue="Congenital myasthenic syndrome" MappingRef="Preferred">
        <MedGen CUI="C0751882" Name="Congenital myasthenic syndrome"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1133593" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided"/>
      </TraitMapping>
    </TraitMappingList>
  </InterpretedRecord>
</VariationArchive>

<VariationArchive VariationID="429390" VariationName="NM_000478.6(ALPL):c.1349G&gt;A (p.Arg450His)" VariationType="single nucleotide variant" DateCreated="2017-06-30" DateLastUpdated="2021-01-02" Accession="VCV000429390" Version="3" RecordType="interpreted" NumberOfSubmissions="4" NumberOfSubmitters="4">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <InterpretedRecord>
    <SimpleAllele AlleleID="421205" VariationID="429390">
      <GeneList>
        <Gene Symbol="ALPL" FullName="alkaline phosphatase, biomineralization associated" GeneID="249" HGNC_ID="HGNC:438" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="21508984" stop="21578412" display_start="21508984" display_stop="21578412" Strand="+"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="21835857" stop="21904904" display_start="21835857" display_stop="21904904" Strand="+"/>
          </Location>
          <OMIM>171760</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000478.6(ALPL):c.1349G&gt;A (p.Arg450His)</Name>
      <CanonicalSPDI>NC_000001.11:21577421:G:A</CanonicalSPDI>
      <VariantType>single nucleotide variant</VariantType>
      <Location>
        <CytogeneticLocation>1p36.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="21577422" stop="21577422" display_start="21577422" display_stop="21577422" variantLength="1" positionVCF="21577422" referenceAlleleVCF="G" alternateAlleleVCF="A"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="21903915" stop="21903915" display_start="21903915" display_stop="21903915" variantLength="1" positionVCF="21903915" referenceAlleleVCF="G" alternateAlleleVCF="A"/>
      </Location>
      <ProteinChange>R450H</ProteinChange>
      <ProteinChange>R395H</ProteinChange>
      <ProteinChange>R373H</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.21903915G&gt;A" Assembly="GRCh37">
            <Expression>NC_000001.10:g.21903915G&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.21577422G&gt;A" Assembly="GRCh38">
            <Expression>NC_000001.11:g.21577422G&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000478.6" sequenceAccession="NM_000478" sequenceVersion="6" change="c.1349G&gt;A" MANESelect="true">
            <Expression>NM_000478.6:c.1349G&gt;A</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000469.3" sequenceAccession="NP_000469" sequenceVersion="3" change="p.Arg450His">
            <Expression>NP_000469.3:p.Arg450His</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127501.4" sequenceAccession="NM_001127501" sequenceVersion="4" change="c.1184G&gt;A">
            <Expression>NM_001127501.4:c.1184G&gt;A</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120973.2" sequenceAccession="NP_001120973" sequenceVersion="2" change="p.Arg395His">
            <Expression>NP_001120973.2:p.Arg395His</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177520.3" sequenceAccession="NM_001177520" sequenceVersion="3" change="c.1118G&gt;A">
            <Expression>NM_001177520.3:c.1118G&gt;A</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001170991.1" sequenceAccession="NP_001170991" sequenceVersion="1" change="p.Arg373His">
            <Expression>NP_001170991.1:p.Arg373His</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369803.2" sequenceAccession="NM_001369803" sequenceVersion="2" change="c.1349G&gt;A">
            <Expression>NM_001369803.2:c.1349G&gt;A</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356732.1" sequenceAccession="NP_001356732" sequenceVersion="1" change="p.Arg450His">
            <Expression>NP_001356732.1:p.Arg450His</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369804.2" sequenceAccession="NM_001369804" sequenceVersion="2" change="c.1349G&gt;A">
            <Expression>NM_001369804.2:c.1349G&gt;A</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356733.1" sequenceAccession="NP_001356733" sequenceVersion="1" change="p.Arg450His">
            <Expression>NP_001356733.1:p.Arg450His</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369805.2" sequenceAccession="NM_001369805" sequenceVersion="2" change="c.1349G&gt;A">
            <Expression>NM_001369805.2:c.1349G&gt;A</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356734.1" sequenceAccession="NP_001356734" sequenceVersion="1" change="p.Arg450His">
            <Expression>NP_001356734.1:p.Arg450His</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008940.1" sequenceAccession="NG_008940" sequenceVersion="1" change="g.73058G&gt;A">
            <Expression>NG_008940.1:g.73058G&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA666829" DB="ClinGen"/>
        <XRef Type="rs" ID="150799088" DB="dbSNP"/>
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00040" Source="1000 Genomes Project"/>
        <AlleleFrequency Value="0.00009" Source="Exome Aggregation Consortium (ExAC)"/>
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)"/>
        <AlleleFrequency Value="0.00008" Source="The Genome Aggregation Database (gnomAD), exomes"/>
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server"/>
      </AlleleFrequencyList>
      <GlobalMinorAlleleFrequency Value="0.00040" Source="1000 Genomes Project" MinorAllele="A"/>
    </SimpleAllele>
    <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
    <RCVList>
      <RCVAccession Title="NM_000478.6(ALPL):c.1349G&gt;A (p.Arg450His) AND Infantile hypophosphatasia" DateLastEvaluated="2017-11-14" ReviewStatus="criteria provided, single submitter" Interpretation="Uncertain significance" SubmissionCount="1" Accession="RCV000670256" Version="1">
        <InterpretedConditionList TraitSetID="3766">
          <InterpretedCondition DB="MedGen" ID="C0268412">Infantile hypophosphatasia</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
      <RCVAccession Title="NM_000478.6(ALPL):c.1349G&gt;A (p.Arg450His) AND not provided" DateLastEvaluated="2017-12-11" ReviewStatus="criteria provided, multiple submitters, no conflicts" Interpretation="Uncertain significance" SubmissionCount="2" Accession="RCV000755807" Version="2">
        <InterpretedConditionList TraitSetID="9460">
          <InterpretedCondition DB="MedGen" ID="CN517202">not provided</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
      <RCVAccession Title="NM_000478.6(ALPL):c.1349G&gt;A (p.Arg450His) AND Hypophosphatasia" DateLastEvaluated="2020-09-16" ReviewStatus="no assertion criteria provided" Interpretation="Uncertain significance" SubmissionCount="1" Accession="RCV001275111" Version="1">
        <InterpretedConditionList TraitSetID="8894">
          <InterpretedCondition DB="MedGen" ID="C0020630">Hypophosphatasia</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
    </RCVList>
    <Interpretations>
      <Interpretation DateLastEvaluated="2017-12-11" NumberOfSubmissions="4" NumberOfSubmitters="4" Type="Clinical significance">
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">10679946</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17212778</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25023282</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3766" Type="Disease">
            <Trait ID="2390" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Infantile hypophosphatasia</ElementValue>
                <XRef ID="Infantile+hypophosphatasia/8660" DB="Genetic Alliance"/>
                <XRef ID="55236002" DB="SNOMED CT"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphoethanolaminuria</ElementValue>
                <XRef ID="HP:0003239" DB="Human Phenotype Ontology"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">High urine phosphoethanolamine levels</ElementValue>
                <XRef ID="HP:0003239" DB="Human Phenotype Ontology"/>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HOPS</ElementValue>
                <XRef Type="MIM" ID="241500" DB="OMIM"/>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of bone and/or teeth in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. Although the disease spectrum is a continuum, six clinical forms are usually recognized based on age at diagnosis and severity of features: Perinatal (severe) hypophosphatasia characterized by respiratory insufficiency and hypercalcemia. Perinatal (benign) hypophosphatasia with prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile hypophosphatasia with onset between birth and age six months of rickets without elevated serum alkaline phosphatase activity. Childhood (juvenile) hypophosphatasia that ranges from low bone mineral density for age with unexplained fractures to rickets, and premature loss of primary teeth with intact roots. Adult hypophosphatasia characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews"/>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061990</ID>
              </Citation>
              <XRef ID="247651" DB="Orphanet"/>
              <XRef ID="436" DB="Orphanet"/>
              <XRef ID="C0268412" DB="MedGen"/>
              <XRef ID="MONDO:0009427" DB="MONDO"/>
              <XRef Type="MIM" ID="241500" DB="OMIM"/>
              <XRef Type="primary" ID="HP:0003239" DB="Human Phenotype Ontology"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="8894" Type="Disease">
            <Trait ID="14484" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypophosphatasia</ElementValue>
                <XRef ID="23875" DB="GeneTests"/>
                <XRef ID="Hypophosphatasia/3677" DB="Genetic Alliance"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphoethanol-aminuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypophosphatasia mild</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of bone and/or teeth in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. Although the disease spectrum is a continuum, six clinical forms are usually recognized based on age at diagnosis and severity of features: Perinatal (severe) hypophosphatasia characterized by respiratory insufficiency and hypercalcemia. Perinatal (benign) hypophosphatasia with prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile hypophosphatasia with onset between birth and age six months of rickets without elevated serum alkaline phosphatase activity. Childhood (juvenile) hypophosphatasia that ranges from low bone mineral density for age with unexplained fractures to rickets, and premature loss of primary teeth with intact roots. Adult hypophosphatasia characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews"/>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6734"/>
                <XRef ID="6734" DB="Office of Rare Diseases"/>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <XRef ID="436" DB="Orphanet"/>
              <XRef ID="C0020630" DB="MedGen"/>
              <XRef ID="MONDO:0018570" DB="MONDO"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit,King Faisal Specialist Hospital &amp; Research Centre"/>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </Interpretation>
    </Interpretations>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1545392" DateCreated="2018-08-01" DateLastUpdated="2019-03-31" SubmissionDate="2018-07-10">
        <ClinVarSubmissionID localKey="2704|OMIM:241500" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000795089" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2017-11-14">
          <Description>Uncertain significance</Description>
          <Citation>
            <ID Source="PubMed">25023282</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10679946</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17212778</ID>
          </Citation>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/3ys2zqtz/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALPL"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="A" referenceAllele="G" start="21903915" stop="21903915" variantLength="1"/>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.4:c.1349G&gt;A</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241500" Type="MIM"/>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1729516" DateCreated="2019-02-15" DateLastUpdated="2020-08-12" SubmissionDate="2018-10-10">
        <ClinVarSubmissionID localKey="191296|Not Provided" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000883391" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2017-12-11">
          <Description>Uncertain significance</Description>
          <Comment>The ALPL: p.Arg450His variant (also reported as R433H; rs150799088) has been previously reported in a patient with odontohypophosphatasia (Taillandier 2000). The patient described in Taillandier et al (2000) also carried a second rare ALPL variant, but further inheritance information, including the phase of the two ALPL variants was not provided. Function studies of the p.Arg450His variant in cell culture could not identify an enzymatic defect (Nasu 2006), although a different variant in the same codon, p.Arg450Cys, lead to a severe disruption in enzyme function (Nasu 2006). However, the p.Arg450Cys variant has been identified as a homozygote in individuals with severe hypophosphatasia (Mornet 1988), and the function defects described in Nasu et al (2006) are likely attributable to the substituted cysteine residue. Furthermore, the p.Arg450His variant is listed in the Genome Aggregation Database (gnomAD) browser with a frequency in South Asian populations of 0.04% (identified in 13 out of 30,690 chromosomes, including 1 homozygote). Therefore, based on the available information, the clinical significance of the p.Arg450His variant cannot be determined with certainty.</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="A" referenceAllele="G" start="21903915" stop="21903915" variantLength="1"/>
          </Location>
          <OtherNameList>
            <Name>p.Arg450His</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="150799088" Type="rsNumber"/>
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.4:c.1349G&gt;A</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4618058</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1133708" DateCreated="2017-06-30" DateLastUpdated="2019-05-09" SubmissionDate="2019-01-29">
        <ClinVarSubmissionID localKey="GDX:696994|Not Provided" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000581949" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2017-05-05">
          <Description>Uncertain significance</Description>
          <Comment Type="public">The R450H variant in the ALPL gene has been reported previously, using alternate nomenclature R433H, in the heterozygous state with a second identified ALPL variant in an individual with odontohypophosphatasia; however, additional clinical and family segregation information were not provided (Taillandier et al., 2000). Functional studies of R450H indicated that it had no drastic effect on enzyme function compared to wild type (Nasu et al., 2006). A missense variant at the same residue, R450C, was previously identified, using alternate nomenclature R433C, in the homozygous state in individuals with infantile hypophosphatasia (Mornet et al., 1998; Whyte et al., 2006). The R450H variant is observed in 7/16324 (0.04%) alleles from individuals of South Asian background in the ExAC dataset (Lek et al., 2016). The R450H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved in mammals. We interpret R450H as a variant of uncertain significance.</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALPL"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="A" referenceAllele="G" start="21903915" stop="21903915" variantLength="1"/>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.4:c.1349G&gt;A</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2875162" DateCreated="2020-12-30" DateLastUpdated="2021-01-01" SubmissionDate="2020-12-28">
        <ClinVarSubmissionID localKey="NM_000478.6:c.1349G&gt;A|Hypophosphatasia" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV001459887" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Interpretation DateLastEvaluated="2020-09-16">
          <Description>Uncertain significance</Description>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.6:c.1349G&gt;A</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hypophosphatasia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1133708" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1545392" TraitType="Disease" MappingType="XRef" MappingValue="241500" MappingRef="OMIM">
        <MedGen CUI="C0268412" Name="Infantile hypophosphatasia"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2875162" TraitType="Disease" MappingType="Name" MappingValue="Hypophosphatasia" MappingRef="Preferred">
        <MedGen CUI="C0020630" Name="Hypophosphatasia"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1729516" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided"/>
      </TraitMapping>
    </TraitMappingList>
  </InterpretedRecord>
</VariationArchive>

<VariationArchive VariationID="429443" VariationName="NM_000094.3(COL7A1):c.887del (p.Gly296fs)" VariationType="Deletion" DateCreated="2017-06-30" DateLastUpdated="2021-01-02" Accession="VCV000429443" Version="3" RecordType="interpreted" NumberOfSubmissions="2" NumberOfSubmitters="2">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <InterpretedRecord>
    <SimpleAllele AlleleID="421449" VariationID="429443">
      <GeneList>
        <Gene Symbol="COL7A1" FullName="collagen type VII alpha 1 chain" GeneID="1294" HGNC_ID="HGNC:2214" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48564073" stop="48595329" display_start="48564073" display_stop="48595329" Strand="-"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48601505" stop="48632592" display_start="48601505" display_stop="48632592" Strand="-"/>
          </Location>
          <OMIM>120120</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000094.3(COL7A1):c.887del (p.Gly296fs)</Name>
      <CanonicalSPDI>NC_000003.12:48592658:CCCC:CCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48592659" stop="48592659" display_start="48592659" display_stop="48592659" variantLength="1" positionVCF="48592658" referenceAlleleVCF="AC" alternateAlleleVCF="A"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48630092" stop="48630092" display_start="48630092" display_stop="48630092" variantLength="1" positionVCF="48630091" referenceAlleleVCF="AC" alternateAlleleVCF="A"/>
      </Location>
      <ProteinChange>G296fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48630095del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48630095del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48592662del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48592662del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.3" sequenceAccession="NM_000094" sequenceVersion="3" change="c.887del">
            <Expression>NM_000094.3:c.887del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000085.1" sequenceAccession="NP_000085" sequenceVersion="1" change="p.Gly296fs">
            <Expression>NP_000085.1:p.Gly296fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_286t1" sequenceAccession="LRG_286t1" change="c.887del">
            <Expression>LRG_286t1:c.887del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_286p1" sequenceAccession="LRG_286p1" change="p.Gly296fs">
            <Expression>LRG_286p1:p.Gly296fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.3" sequenceAccession="NM_000094" sequenceVersion="3" change="c.887delG">
            <Expression>NM_000094.3:c.887delG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO"/>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007065.1" sequenceAccession="NG_007065" sequenceVersion="1" change="g.7594del">
            <Expression>NG_007065.1:g.7594del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_286" sequenceAccession="LRG_286" change="g.7594del">
            <Expression>LRG_286:g.7594del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645369335" DB="ClinGen"/>
        <XRef Type="rs" ID="1131691385" DB="dbSNP"/>
      </XRefList>
    </SimpleAllele>
    <ReviewStatus>criteria provided, single submitter</ReviewStatus>
    <RCVList>
      <RCVAccession Title="NM_000094.3(COL7A1):c.887del (p.Gly296fs) AND not provided" DateLastEvaluated="2017-12-29" ReviewStatus="criteria provided, single submitter" Interpretation="Pathogenic" SubmissionCount="1" Accession="RCV000493245" Version="2">
        <InterpretedConditionList TraitSetID="9460">
          <InterpretedCondition DB="MedGen" ID="CN517202">not provided</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
      <RCVAccession Title="NM_000094.3(COL7A1):c.887del (p.Gly296fs) AND Epidermolysis bullosa dystrophica inversa, autosomal recessive" DateLastEvaluated="2020-09-16" ReviewStatus="no assertion criteria provided" Interpretation="Pathogenic" SubmissionCount="1" Accession="RCV001273343" Version="1">
        <InterpretedConditionList TraitSetID="5738">
          <InterpretedCondition DB="MedGen" ID="C2673612">Epidermolysis bullosa dystrophica inversa, autosomal recessive</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
    </RCVList>
    <Interpretations>
      <Interpretation DateLastEvaluated="2017-12-29" NumberOfSubmissions="2" NumberOfSubmitters="2" Type="Clinical significance">
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5738" Type="Disease">
            <Trait ID="8933" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa dystrophica inversa, autosomal recessive</ElementValue>
              </Name>
              <XRef ID="C2673612" DB="MedGen"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit,King Faisal Specialist Hospital &amp; Research Centre"/>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </Interpretation>
    </Interpretations>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1133778" DateCreated="2017-06-30" DateLastUpdated="2019-05-09" SubmissionDate="2019-01-29">
        <ClinVarSubmissionID localKey="GDX:725098|Not Provided" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000582019" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2017-12-29">
          <Description>Pathogenic</Description>
          <Comment Type="public">The c.887delG variant in the COL7A1 gene has been reported previously in association with RDEB (Christiano et al., 1996). The c.887delG variant causes a frameshift starting with codon Glycine 296, changes this amino acid to a Valine residue, and creates a premature Stop codon at position 5 of the new reading frame, denoted p.Gly296ValfsX5. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.887delG variant is not observed in large population cohort (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.887delG as a pathogenic variant.</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.887delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2871578" DateCreated="2020-12-30" DateLastUpdated="2021-01-01" SubmissionDate="2020-12-28">
        <ClinVarSubmissionID localKey="NM_000094.3:c.887delG|Autosomal recessive epidermolysis bullosa dystrophica inversa" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV001456303" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Interpretation DateLastEvaluated="2020-09-16">
          <Description>Pathogenic</Description>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.887delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Autosomal recessive epidermolysis bullosa dystrophica inversa</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1133778" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2871578" TraitType="Disease" MappingType="Name" MappingValue="Autosomal recessive epidermolysis bullosa dystrophica inversa" MappingRef="Preferred">
        <MedGen CUI="C2673612" Name="Epidermolysis bullosa dystrophica inversa, autosomal recessive"/>
      </TraitMapping>
    </TraitMappingList>
  </InterpretedRecord>
</VariationArchive>

<VariationArchive VariationID="429490" VariationName="NM_015120.4(ALMS1):c.10357A&gt;G (p.Asn3453Asp)" VariationType="single nucleotide variant" DateCreated="2017-06-30" DateLastUpdated="2021-01-02" Accession="VCV000429490" Version="3" RecordType="interpreted" NumberOfSubmissions="3" NumberOfSubmitters="3">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <InterpretedRecord>
    <SimpleAllele AlleleID="421407" VariationID="429490">
      <GeneList>
        <Gene Symbol="ALMS1" FullName="ALMS1 centrosome and basal body associated protein" GeneID="7840" HGNC_ID="HGNC:428" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="73385758" stop="73609919" display_start="73385758" display_stop="73609919" Strand="+"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="73612885" stop="73837045" display_start="73612885" display_stop="73837045" Strand="+"/>
          </Location>
          <OMIM>606844</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015120.4(ALMS1):c.10357A&gt;G (p.Asn3453Asp)</Name>
      <CanonicalSPDI>NC_000002.12:73559111:A:G</CanonicalSPDI>
      <VariantType>single nucleotide variant</VariantType>
      <Location>
        <CytogeneticLocation>2p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="73559112" stop="73559112" display_start="73559112" display_stop="73559112" variantLength="1" positionVCF="73559112" referenceAlleleVCF="A" alternateAlleleVCF="G"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="73786239" stop="73786239" display_start="73786239" display_stop="73786239" variantLength="1" positionVCF="73786239" referenceAlleleVCF="A" alternateAlleleVCF="G"/>
      </Location>
      <ProteinChange>N3453D</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.73786239A&gt;G" Assembly="GRCh37">
            <Expression>NC_000002.11:g.73786239A&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.73559112A&gt;G" Assembly="GRCh38">
            <Expression>NC_000002.12:g.73559112A&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015120.4" sequenceAccession="NM_015120" sequenceVersion="4" change="c.10357A&gt;G">
            <Expression>NM_015120.4:c.10357A&gt;G</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055935.4" sequenceAccession="NP_055935" sequenceVersion="4" change="p.Asn3453Asp">
            <Expression>NP_055935.4:p.Asn3453Asp</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_741t1" sequenceAccession="LRG_741t1" change="c.10357A&gt;G">
            <Expression>LRG_741t1:c.10357A&gt;G</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_741p1" sequenceAccession="LRG_741p1" change="p.Asn3453Asp">
            <Expression>LRG_741p1:p.Asn3453Asp</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_741" sequenceAccession="LRG_741" change="g.178360A&gt;G">
            <Expression>LRG_741:g.178360A&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011690.1" sequenceAccession="NG_011690" sequenceVersion="1" change="g.178360A&gt;G">
            <Expression>NG_011690.1:g.178360A&gt;G</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="573748379" DB="dbSNP"/>
        <XRef ID="CA1714970" DB="ClinGen"/>
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes"/>
        <AlleleFrequency Value="0.00006" Source="The Genome Aggregation Database (gnomAD)"/>
        <AlleleFrequency Value="0.00009" Source="Trans-Omics for Precision Medicine (TOPMed)"/>
        <AlleleFrequency Value="0.00080" Source="1000 Genomes Project"/>
        <AlleleFrequency Value="0.00005" Source="Exome Aggregation Consortium (ExAC)"/>
      </AlleleFrequencyList>
      <GlobalMinorAlleleFrequency Value="0.00080" Source="1000 Genomes Project" MinorAllele="G"/>
    </SimpleAllele>
    <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
    <RCVList>
      <RCVAccession Title="NM_015120.4(ALMS1):c.10357A&gt;G (p.Asn3453Asp) AND not specified" DateLastEvaluated="2017-03-06" ReviewStatus="criteria provided, single submitter" Interpretation="Uncertain significance" SubmissionCount="1" Accession="RCV000494528" Version="3">
        <InterpretedConditionList TraitSetID="9590">
          <InterpretedCondition DB="MedGen" ID="CN169374">not specified</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
      <RCVAccession Title="NM_015120.4(ALMS1):c.10357A&gt;G (p.Asn3453Asp) AND not provided" DateLastEvaluated="2017-05-10" ReviewStatus="criteria provided, single submitter" Interpretation="Uncertain significance" SubmissionCount="1" Accession="RCV000766679" Version="1">
        <InterpretedConditionList TraitSetID="9460">
          <InterpretedCondition DB="MedGen" ID="CN517202">not provided</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
      <RCVAccession Title="NM_015120.4(ALMS1):c.10357A&gt;G (p.Asn3453Asp) AND Alstrom syndrome" DateLastEvaluated="2020-09-16" ReviewStatus="no assertion criteria provided" Interpretation="Uncertain significance" SubmissionCount="1" Accession="RCV001271700" Version="1">
        <InterpretedConditionList TraitSetID="1087">
          <InterpretedCondition DB="MedGen" ID="C0268425">Alstrom syndrome</InterpretedCondition>
        </InterpretedConditionList>
      </RCVAccession>
    </RCVList>
    <Interpretations>
      <Interpretation DateLastEvaluated="2017-05-10" NumberOfSubmissions="3" NumberOfSubmitters="3" Type="Clinical significance">
        <Description>Uncertain significance</Description>
        <ConditionList>
          <TraitSet ID="9590" Type="Disease">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit,King Faisal Specialist Hospital &amp; Research Centre"/>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen"/>
            </Trait>
          </TraitSet>
          <TraitSet ID="1087" Type="Disease">
            <Trait ID="207" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Alstrom syndrome</ElementValue>
                <XRef ID="Alstrom+Syndrome/341" DB="Genetic Alliance"/>
                <XRef ID="63702009" DB="SNOMED CT"/>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alstrom's syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ALSS</ElementValue>
                <XRef Type="MIM" ID="203800" DB="OMIM"/>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ALMS</ElementValue>
                <XRef Type="MIM" ID="203800" DB="OMIM"/>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Alström syndrome is characterized by cone-rod dystrophy, obesity, progressive bilateral sensorineural hearing impairment, acute infantile-onset cardiomyopathy and/or adolescent- or adult-onset restrictive cardiomyopathy, insulin resistance / type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), and chronic progressive kidney disease. Cone-rod dystrophy presents as progressive visual impairment, photophobia, and nystagmus usually starting between birth and age 15 months. Many individuals lose all perception of light by the end of the second decade, but a minority retain the ability to read large print into the third decade. Children usually have normal birth weight but develop truncal obesity during their first year. Sensorineural hearing loss presents in the first decade in as many as 70% of individuals and may progress to the severe or moderately severe range (40-70 db) by the end of the first to second decade. Insulin resistance is typically accompanied by the skin changes of acanthosis nigricans, and proceeds to T2DM in the majority by the third decade. Nearly all demonstrate hypertriglyceridemia. Other findings can include endocrine abnormalities (hypothyroidism, hypogonadotropic hypogonadism in males, and hyperandrogenism in females), urologic dysfunction / detrusor instability, progressive decrease in renal function, and hepatic disease (ranging from elevated transaminases to steatohepatitis/NAFLD). Approximately 20% of affected individuals have delay in early developmental milestones, most commonly in gross and fine motor skills. About 30% have a learning disability. Cognitive impairment (IQ &lt;70) is very rare. Wide clinical variability is observed among affected individuals, even within the same family.</Attribute>
                <XRef ID="NBK1267" DB="GeneReviews"/>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5787"/>
                <XRef ID="5787" DB="Office of Rare Diseases"/>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301444</ID>
                <ID Source="BookShelf">NBK1267</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21522186</ID>
              </Citation>
              <XRef ID="64" DB="Orphanet"/>
              <XRef ID="C0268425" DB="MedGen"/>
              <XRef ID="MONDO:0008763" DB="MONDO"/>
              <XRef Type="MIM" ID="203800" DB="OMIM"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </Interpretation>
    </Interpretations>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1689835" DateCreated="2019-01-09" DateLastUpdated="2019-03-31" SubmissionDate="2018-12-12">
        <ClinVarSubmissionID localKey="NM_015120.4:c.10357A&gt;G|MedGen:CN169374" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000864098" Type="SCV" Version="1" SubmitterName="Integrated Genetics/Laboratory Corporation of America" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="IG"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2017-03-06">
          <Description>Uncertain significance</Description>
          <Comment Type="public">Variant summary: The ALMS1 c.10351A&gt;G (p.Asn3451Asp, alternative name c.10357A&gt;G) variant involves the alteration of a non-conserved nucleotide and is predicted to be benign by 4/4 in silico tools (SNPs&amp;GO not captured due to low reliability index). It is located outside of some of known domains and repeats in ALMS1 protein (InterPro, UniProt). This variant was found in 6/117580 control chromosomes at a frequency of 0.000051, which does not exceed the estimated maximal expected allele frequency of a pathogenic ALMS1 variant (0.0022361). The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available.</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALMS1"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015120.4:c.10357A&gt;G</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN169374" Type="CUI"/>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2018_12_ALMS1_updates</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1133832" DateCreated="2017-06-30" DateLastUpdated="2019-05-09" SubmissionDate="2019-01-29">
        <ClinVarSubmissionID localKey="GDX:1593100|Not Provided" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000582073" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Interpretation DateLastEvaluated="2017-05-10">
          <Description>Uncertain significance</Description>
          <Comment Type="public">The N3453D variant of uncertain significance in the ALMS1 gene has not been published as pathogenic or been reported as benign to our knowledge. The N3453D variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. However, this substitution occurs at a position that is not conserved across species, and aspartic acid is the wild-type amino acid at this position in multiple species. In silico analysis predicts this variant likely does not alter the protein structure/function. Furthermore, N3453D was observed in 5/9,476 alleles from individuals of African ancestry in the Exome Aggregation Consortium (ExAC) dataset (Lek et al., 2016).</Comment>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALMS1"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="G" referenceAllele="A" start="73786239" stop="73786239" variantLength="1"/>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015120.4:c.10357A&gt;G</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2868318" DateCreated="2020-12-30" DateLastUpdated="2021-01-01" SubmissionDate="2020-12-28">
        <ClinVarSubmissionID localKey="NM_015120.4:c.10357A&gt;G|Alstrom syndrome" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV001453043" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory"/>
        <RecordStatus>current</RecordStatus>
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Interpretation DateLastEvaluated="2020-09-16">
          <Description>Uncertain significance</Description>
        </Interpretation>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015120.4:c.10357A&gt;G</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Alstrom syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1133832" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1689835" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2868318" TraitType="Disease" MappingType="Name" MappingValue="Alstrom syndrome" MappingRef="Preferred">
        <MedGen CUI="C0268425" Name="Alstrom syndrome"/>
      </TraitMapping>
    </TraitMappingList>
  </InterpretedRecord>
</VariationArchive>

</ClinVarVariationRelease>